UAB selected to host clinical trial for possible COVID-19 treatment

This post was originally published on this site

UAB has been selected as one of 75 sites in the world to host clinical trials for a possible COVID-19 treatment, according to an article on the UAB News website. Remdesivir is the first agent they will evaluate. The National Institute of Allergy and Infectious …

Click here to read full article